These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 16734876

  • 1. Breast metastasis from prostate cancer and interpretation of immunoreactivity to prostate-specific antigen.
    Cheng CW, Chan LW, Ng CF, Chan CK, Tse MK, Lai MM.
    Int J Urol; 2006 Apr; 13(4):463-5. PubMed ID: 16734876
    [Abstract] [Full Text] [Related]

  • 2. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
    Hansel DE, DeMarzo AM, Platz EA, Jadallah S, Hicks J, Epstein JI, Partin AW, Netto GJ.
    J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
    [Abstract] [Full Text] [Related]

  • 3. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
    Connolly D, Black A, Murray LJ, Nambirajan T, Keane PF, Gavin A.
    Prostate Cancer Prostatic Dis; 2009 May; 12(1):47-51. PubMed ID: 18762815
    [Abstract] [Full Text] [Related]

  • 4. [The density of prostate specific antigen of the transition zone as an early predictor of prostate cancer].
    Topuzov ME, Prialukhin AE, Zhivov AV, Plekhanov AIu.
    Vestn Khir Im I I Grek; 2008 May; 167(6):119-21. PubMed ID: 19241832
    [Abstract] [Full Text] [Related]

  • 5. [A prostatic duct carcinoma difficult to distinguish from transitional cell carcinoma: a case report].
    Ushida H, Koizumi S, Okada Y.
    Hinyokika Kiyo; 2004 Aug; 50(8):535-8. PubMed ID: 15471072
    [Abstract] [Full Text] [Related]

  • 6. Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer.
    Saito T, Hara N, Kitamura Y, Komatsubara S.
    Urology; 2007 Oct; 70(4):702-5. PubMed ID: 17991541
    [Abstract] [Full Text] [Related]

  • 7. [Value of prostate specific antigen in early diagnosis of prostatic cancer].
    Xiao LP, Bi XJ, Li YN, Chen XQ, Zhang XF, Yu XP, Liu G, Yang MC, Song Z.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):107-8, 112. PubMed ID: 17259162
    [Abstract] [Full Text] [Related]

  • 8. [Immunohistochemical study of the prostate-specific antigen in prostatic cancer].
    Karseladze AI, Rytin IIe, Budunova IV.
    Arkh Patol; 2004 Jan; 66(2):3-7. PubMed ID: 15154373
    [Abstract] [Full Text] [Related]

  • 9. [Recrudescence of prostate cancer with low serum level of PSA and high serum level of CEA and CA19-9: a case report].
    Yokoyama S, Fukuhara S, Imazu T, Hara T, Yamaguchi S, Adachi S.
    Hinyokika Kiyo; 2007 Jul; 53(7):485-7. PubMed ID: 17702183
    [Abstract] [Full Text] [Related]

  • 10. Markedly raised serum prostate specific antigen levels. Prostatic infarction rather than malignancy?
    Kiran PR.
    Aust Fam Physician; 2001 May; 30(5):458-60. PubMed ID: 11432019
    [Abstract] [Full Text] [Related]

  • 11. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W, Epstein JI.
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [Abstract] [Full Text] [Related]

  • 12. [Bilateral breast metastases from prostatic carcinoma: a case report].
    Soda T, Onishi H, Terachi T, Oishi K, Takeuchi H, Yoshida O.
    Hinyokika Kiyo; 1999 Apr; 45(4):269-71. PubMed ID: 10363149
    [Abstract] [Full Text] [Related]

  • 13. [A case report: mucinous carcinoma of prostate].
    Noma M, Mori N, Kobayashi Y, Hara T, Yamaguchi S.
    Hinyokika Kiyo; 2003 Oct; 49(10):591-3. PubMed ID: 14655602
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free: total PSA ratios in a consecutive series of men referred for prostate biopsies.
    Rydén L, Egevad L, Ekman P, Hellström M.
    Scand J Urol Nephrol; 2007 Oct; 41(4):302-7. PubMed ID: 17763221
    [Abstract] [Full Text] [Related]

  • 15. Prostate-specific antigen velocity and the detection of gleason score 7 to 10 prostate cancer.
    Punglia RS, Cullen J, McLeod DG, Chen Y, D'Amico AV.
    Cancer; 2007 Nov 01; 110(9):1973-8. PubMed ID: 17886252
    [Abstract] [Full Text] [Related]

  • 16. [A case of primary transitional cell carcinoma of the prostate].
    Morikawa H, Cho M, Takada S, Fujimoto K, Uemura H, Ozono S, Hirao Y, Natsume O.
    Hinyokika Kiyo; 2003 Jun 01; 49(6):357-60. PubMed ID: 12894737
    [Abstract] [Full Text] [Related]

  • 17. Expression of prostate specific antigen in male breast cancer.
    Carder PJ, Speirs V, Ramsdale J, Lansdown MR.
    J Clin Pathol; 2005 Jan 01; 58(1):69-71. PubMed ID: 15623486
    [Abstract] [Full Text] [Related]

  • 18. Prostate-specific antigen velocity and prostate cancer gleason grade and stage.
    Pinsky PF, Andriole G, Crawford ED, Chia D, Kramer BS, Grubb R, Greenlee R, Gohagan JK.
    Cancer; 2007 Apr 15; 109(8):1689-95. PubMed ID: 17330856
    [Abstract] [Full Text] [Related]

  • 19. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
    Walz J, Haese A, Scattoni V, Steuber T, Chun FK, Briganti A, Montorsi F, Graefen M, Huland H, Karakiewicz PI.
    Cancer; 2008 Nov 15; 113(10):2695-703. PubMed ID: 18853417
    [Abstract] [Full Text] [Related]

  • 20. Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review.
    D'Aprile M, Santini D, Di Cosimo S, Gravante G, Vincenzi B, Spoto S, Costantino S, Rabitti C, Tonini G.
    Clin Ter; 2000 Nov 15; 151(5):371-4. PubMed ID: 11141722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.